© 2026 All Rights reserved WUSF
Donate
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations
WUSF's Wake Up Call
Our daily newsletter, delivered first thing weekdays, keeps you connected to your community with news, culture, national NPR headlines, and more.
Subscribe

What's the latest with the Trump admin's promise on lower drug prices in Medicaid?

NPR | By Sydney Lupkin,
Scott Detrow
Published September 14, 2026 at 4:34 PM EDT

The Trump admin's drug price deals came with a promise to offer lower prices in Medicaid. But the goalposts keep moving. Instead of all drugs, it's just one or two. And the deadlines for states to voluntarily sign on has been pushed back twice. So what's the status?

Copyright 2026 NPR
Tags
All Things ConsideredNPR Health
Sydney Lupkin
Sydney Lupkin is the pharmaceuticals correspondent for NPR, where she has reported on accelerated drug approvals whose confirmatory trials were overdue, Operation Warp Speed contract accountability, and the ripple effects of obesity drug shortages. 
See stories by Sydney Lupkin
Scott Detrow
Scott Detrow is a host of All Things Considered, as well as NPR’s daily news podcast Consider This.
See stories by Scott Detrow
Thanks to you, WUSF is here — delivering fact-based news and stories that reflect our community.⁠ Your support powers everything we do.
Donate Now